Company profile for Galapagos

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biotechnology company, focused on the development and commercialization of novel medicines that will improve people's lives. We seek to develop a robust portfolio of clinical-stage breakthrough therapies that have the potential to re...
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biotechnology company, focused on the development and commercialization of novel medicines that will improve people's lives. We seek to develop a robust portfolio of clinical-stage breakthrough therapies that have the potential to revolutionize existing treatment paradigms. Our ambition is to become a leading global biotechnological company, focused on the development and commercialization of novel medicines that will improve people’s lives.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Belgium
Address
Address
Galapagos NV Generaal De Wittelaan L11 A3 2800 Mechelen, Belgium
Telephone
Telephone
+3215342900
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/26/3194851/0/en/Galapagos-Receives-Transparency-Notifications-from-Bank-of-America.html

GLOBENEWSWIRE
26 Nov 2025

https://www.fiercebiotech.com/biotech/gilead-wants-us-rebuild-why-galapagos-cant-go-extinct-despite-turbulent-year

FIERCE BIOTECH
19 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181906/0/en/Galapagos-Reports-Nine-Months-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/11/03/3179746/0/en/Galapagos-to-Present-New-Data-from-Cell-Therapy-Program-at-ASH-2025.html

GLOBENEWSWIRE
03 Nov 2025

https://www.globenewswire.com/news-release/2025/10/30/3177873/0/en/Galapagos-Announces-Changes-to-its-Board-to-Accelerate-Strategic-Focus-on-Business-Development.html

GLOBENEWSWIRE
30 Oct 2025

https://www.globenewswire.com/news-release/2025/10/23/3172415/0/en/Galapagos-to-Present-In-Vitro-Data-at-ACR-Convergence-2025-Suggesting-Differentiation-of-GLPG3667-from-Other-TYK2-Inhibitors.html

GLOBENEWSWIRE
23 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty